Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Acorda Therapeutics announces top line results of post-marketing commitment study exploring 5 mg dose of dalfampridine-ER
An Open Label Extension of the LAQ/5062 and LAQ/5063 Studies to Assess the Long Term Safety and Tolerability of Laquinimod 0.6mg in RRMS Patients
"Undiagnosing" multiple sclerosis: The challenge of misdiagnosis in MS.
Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma
Vitamin D3 Receptor ( VDR ) Gene rs2228570 (Fok1) and rs731236 (Taq1) Variants Are Not Associated with the Risk for Multiple Sclerosis: Results of a New Study and a Meta-Analysis.
Effect of High-Dose Intravenous Methyl-prednisolone Treatment on Intraocular Pressure in Multiple Sclerosis Patients with Relapse.
Expression and activation by epstein barr virus of human endogenous retroviruses-w in blood cells and astrocytes: inference for multiple sclerosis.
Multiple sclerosis.
The Many Facets of Cell Injury: Angiogenesis to Autophagy.
Rehabilitation interventions in multiple sclerosis: an overview.
Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus.
Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS.
LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
Inhibition of glycerophosphate-dependent H2O2 generation in brown fat mitochondria by idebenone.
Sodium accumulation is associated with disability and a progressive course in multiple sclerosis.
Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid.
Rituximab: Don't Count It Out as MS Treatment
Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.
Multiple Sclerosis: Vitamin D and calcium as environmental determinants of prevalence (A Viewpoint)
[Plasmapheresis in central nervous system disorders].
The Impact of Lesion In-Painting and Registration Methods on Voxel-Based Morphometry in Detecting Regional Cerebral Gray Matter Atrophy in Multiple Sclerosis.
Cranial neuropathies in multiple sclerosis defined by magnetic resonance imaging and fludeoxyglucose f 18 positron emission tomography.
It is better to be in a clinical trial than not: lessons learnt from clinical neurology--the management of acute multiple sclerosis relapses.
Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.
Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases.

Pages